Legislation

Oramed Granted Key European Patent for Platform Technology in Oral Delivery of Proteins

Retrieved on: 
Wednesday, January 5, 2022
Knowledge, Method, European Patent Convention, Research, Forward-looking statement, POD, U.S. Securities and Exchange Commission, Opposition procedure before the European Patent Office, Security (finance), Diabetes, Patent, Legislation, Technology, Human, Pressure, Biotechnology, Pharmaceutical industry, Oramed

The patent supports Oramed's oral protein delivery platform technology which underlies its lead drug candidate ORMD-0801 now in pivotal Phase 3 studies and positioned to potentially be the first oral insulin capsule on the market.

Key Points: 
  • The patent supports Oramed's oral protein delivery platform technology which underlies its lead drug candidate ORMD-0801 now in pivotal Phase 3 studies and positioned to potentially be the first oral insulin capsule on the market.
  • The granted patent covers a unique method for the purification of raw protease-inhibiting materials which are a key component of the platform technology that protects therapeutic proteins in the digestive system.
  • Oramed Pharmaceuticals (Nasdaq/TASE: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection.
  • Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD) technology.

Hut 8 Mining Holds 5,518 Self Mined Bitcoin in Reserve as of December 31, 2021; Provides Monthly Production Update for December 2021; Announces US$30 million Equipment Financing with Trinity Capital

Retrieved on: 
Wednesday, January 5, 2022
Knowledge, COVID-19, Trinity, ESG, Finance, Growth, Company, Mining, Goal, Hilltop Holdings Inc., Hut 8, Income, Risk, TSX, Miner, Efficiency, Imagination, CEO, Electricity, Legislation, Hut, Equipment, Nasdaq, CFO, Industry, Investment, Leadership, Cryptocurrency, Animal, Oil, Construction, Security (finance), Bitcoin, Medicine, Medicine Hat

"2021 has been a year of transformation for Hut 8, with a focus on not only rebuilding and upgrading, but future-proofing our operations.

Key Points: 
  • "2021 has been a year of transformation for Hut 8, with a focus on not only rebuilding and upgrading, but future-proofing our operations.
  • We are business-building technologists, with a focus on diversification, while keeping Bitcoin mining at our core.
  • Equipment Financing with Trinity Capital:
    On December 30, 2021, Hut 8 Holdings Inc., a wholly owned operating subsidiary of the Company,entered into a US$30 million senior secured equipment financing term loan with Trinity Capital Inc ("Trinity Capital").
  • "We are pleased to achieve this financing milestone with Trinity Capital," commented Shane Downey, CFO of Hut 8.

MediPharm Labs Completes Payment of All Convertible Debt

Retrieved on: 
Wednesday, January 5, 2022
Longevity, GMP, FSE, Failure, Company, Ownership, Forward-looking statement, Phrase, Contract, CEO, SEDAR, Legislation, News, GLOBE, Industry, OTCQX, Security (finance), Bank

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (MediPharm Labs or the Company) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has completed all payments required under its 2020 $41 million unsecured convertible debt.

Key Points: 
  • TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (MediPharm Labs or the Company) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it has completed all payments required under its 2020 $41 million unsecured convertible debt.
  • MediPharm continues on its plan and path to profitability, and paying off our convertible debt in full is a major milestone on that path, said Bryan Howcroft, CEO, MediPharm Labs.
  • MediPharm Labs has no other material debt and full ownership of its assets, which includes two GMP facilities one in the province of Ontario, Canada and the other in the state of Victoria, Australia.
  • Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

Comstock Acquires Majority Ownership of LiNiCo

Retrieved on: 
Wednesday, January 5, 2022
Gold, Silver, Securities Act of 1933, Electricity, Acquisition, Zhurong (rover), Natural Resources, Government, Recycling, Growth, Zinc, Failure, LIB, Company, Forward-looking statement, Miner, Metal, NYSE, International Energy Agency, Consultant, Securities Exchange Act of 1934, Lithium carbonate, Cobalt, USGS, Risk, Lists of disasters, NASDAQ, Person, SEC, Perception, EVS, Lithium, Nature, Compliance, Comstock, EV, Carbon neutrality, Legislation, Terrorism, Adoption, GLOBE, Technology, Employment, Industry, Nickel, Investment, Public expenditure, Water, Risk management

VIRGINIA CITY, Nev., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Comstock Mining Inc. (NYSE: LODE) (Comstock and the Company) today announced its acquisition of an additional 3,129,081 common shares in LINICO Corporation (LiNiCo) from LiNiCos founder, Michael Vogel, in exchange for 3,500,000 restricted Comstock common shares, and acquired an additional 4,075 Series A Preferred shares, thereby increasing Comstocks overall ownership to approximately 90% from approximately 45% of LiNiCo.

Key Points: 
  • VIRGINIA CITY, Nev., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Comstock Mining Inc. (NYSE: LODE) (Comstock and the Company) today announced its acquisition of an additional 3,129,081 common shares in LINICO Corporation (LiNiCo) from LiNiCos founder, Michael Vogel, in exchange for 3,500,000 restricted Comstock common shares, and acquired an additional 4,075 Series A Preferred shares, thereby increasing Comstocks overall ownership to approximately 90% from approximately 45% of LiNiCo.
  • LiNiCo is an emerging leader in the production of electrification products, including lithium carbonate and graphite from recycled lithium-ion batteries (LIB) with its proprietary extraction technologies.
  • The remaining 10% of LiNiCo is owned by Aqua Metals Inc. (NASDAQ: AQMS), a cleantech innovator focused on environmentally closed-loop battery recycling.
  • LiNiCo would use this technology to process secondary metal concentrates into high-purity nickel, cobalt, and other metals.

Clean Air Metals Drill Results from the Thunder Bay North Project includes 31.0m averaging 3.9 g/t Pt, 5.1 g/t Pd, 1.7% Cu, 0.63% Ni. 2022 drilling set to restart

Retrieved on: 
Wednesday, January 5, 2022
Projection, PPE, COVID-19, Lac, Metal, Mining, Palladium, Gold, Panorama, Geology, Red Rock, MTI, Platinum, View, MSO, Agreement, North American Palladium, Impala, TSX Venture Exchange, PEA, Fort William First Nation, Impala Platinum, Current, Element, Company, ICP-MS, Forward-looking statement, Cobalt, COVID, First Nations, CEO, Chromium, Sale, Copper, ICP-AES, Silver, National instrument, Personal protective equipment, ICP-OES, Legislation, AAS, ALS, British Columbia v Imperial Tobacco Canada Ltd, Multimedia, Nickel, Maintenance, FA, Fortification, Area studies, Oil, Risk management, 3D printing, Thunder Bay North Stars, Norilsk, Escape

There is a total of 37,000m of previously reported drilling results from the Escape Deposit in 2021 which not yet applied to the mineral resource for the Thunder Bay North Project.

Key Points: 
  • There is a total of 37,000m of previously reported drilling results from the Escape Deposit in 2021 which not yet applied to the mineral resource for the Thunder Bay North Project.
  • Up to 16,000m of drilling is also planned to commence in mid-January 2022 on frozen muskeg to follow up on certain discrete geophysical anomalies.
  • The Company is aware of Thunder Bay Health Unit guidelines that provide for "mandatory" self-isolation for returning overseas.
  • The Company has procured the services of a locally staffed and serviced diamond drilling contractor to complete the diamond drilling programs.

CORRECTION - Metallica Metals Closes Private Placement

Retrieved on: 
Wednesday, January 5, 2022
Transport, Thunder Bay, Acquisition, Failure, Mining, Company, Metallica, PGM, Risk, Legislation, News, Industry, Canadian Securities Exchange, Risk management

Metallica Metals Corp. is a Canadian junior mining company listed on the Canadian Securities Exchange (CSE) and its common shares trade under the ticker symbol MM.

Key Points: 
  • Metallica Metals Corp. is a Canadian junior mining company listed on the Canadian Securities Exchange (CSE) and its common shares trade under the ticker symbol MM.
  • The Company is focused on acquiring and exploring gold-silver and platinum group metal (PGM) properties across Canada.
  • This news release contains certain forward-looking information within the meaning of applicable securities law.
  • Readers are cautioned not to place undue reliance on forward-looking information.

Greenberg Traurig Continues to Expand New York Office with Addition of Jason Jendrewski in Labor & Employment

Retrieved on: 
Wednesday, January 5, 2022
Cornell University, Privacy Office of the U.S. Department of Homeland Security, National Labor Relations Board, Medication, Elementary and Secondary Education Act, Title III Part A, GT, Cornell University School of Industrial and Labor Relations, United States Department of Labor, Workplace, Justice, School, Employment practices liability, U.S. Department of Justice Office of Legislative Affairs, Jim Cross, ILR, Government, Brooklyn Law School, Greenberg Traurig, Equal Employment Opportunity Commission, Carbon, LLP, Philippine Senate Committee on Labor, Employment and Human Resources Development, App Store (iOS/iPadOS), Compliance, Legislation, Lawyer, Employment, Risk, Montana Stream Access Law, Industrial relations, Blog, Disability discrimination act, Journal of Employment Counseling, ADA, Public relations, Labour

NEW YORK, Jan. 4, 2022 /PRNewswire-PRWeb/ -- Greenberg Traurig 's New York office continues its strategic growth with the addition of Jason Jendrewski as a shareholder in the global Labor & Employment and ADA and Accessibility Law practices with a focus on public accommodation disability access issues.

Key Points: 
  • NEW YORK, Jan. 4, 2022 /PRNewswire-PRWeb/ -- Greenberg Traurig 's New York office continues its strategic growth with the addition of Jason Jendrewski as a shareholder in the global Labor & Employment and ADA and Accessibility Law practices with a focus on public accommodation disability access issues.
  • Greenberg Traurig has added a total of 11 shareholders and of counsels to its New York office during 2021 across various practice areas.
  • About Greenberg Traurig's Labor & Employment Practice: Greenberg Traurig's Global Labor & Employment Practice serves clients from offices throughout the United States, Latin America, Europe, and Asia.
  • Visit Greenberg Traurig's Labor & Employment Blog for insights and analysis of the latest labor and employment developments, including legislation, regulations, cases, policies, and trends.

Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution

Retrieved on: 
Tuesday, January 4, 2022
Safety, Merz Pharma, Food, Endo International, Regulation of tobacco by the U.S. Food and Drug Administration, Bankruptcy, Merz, Par, Life, U.S. Securities and Exchange Commission, Phrase, Risk, Annual report, General manager, Private Securities Litigation Reform Act, Bromide, NASDAQ, LinkedIn, Senior, Compliance, LLC, Legislation, Industry, Public expenditure, Pharmaceutical industry, IQVIA

"We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Generics at Endo.

Key Points: 
  • "We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Generics at Endo.
  • "Glycopyrrolate oral solution joins our extensive portfolio of high-quality, lower-cost generic productsand our reputation for dependable quality is an especially essential factor when treating children."
  • According to IQVIA, CUVPOSA sales were approximately $27 million for the 12 months ended October 31, 2021.
  • Endo expressly disclaims any intent or obligation to update these forward-looking statements, except as required to do so by law.

Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution

Retrieved on: 
Tuesday, January 4, 2022
Safety, View, Merz Pharma, Food, Endo International, Regulation of tobacco by the U.S. Food and Drug Administration, Bankruptcy, Merz, Par, Life, U.S. Securities and Exchange Commission, Phrase, Risk, Annual report, General manager, Private Securities Litigation Reform Act, Bromide, NASDAQ, LinkedIn, Senior, Compliance, LLC, Legislation, Multimedia, Industry, Public expenditure, Pharmaceutical industry, IQVIA

"We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Generics at Endo.

Key Points: 
  • "We're proud to provide families with a generic option of this important medication," said Jon Holden, Senior Vice President and General Manager, Generics at Endo.
  • "Glycopyrrolate oral solution joins our extensive portfolio of high-quality, lower-cost generic productsand our reputation for dependable quality is an especially essential factor when treating children."
  • According to IQVIA, CUVPOSA sales were approximately $27 million for the 12 months ended October 31, 2021.
  • Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies.

Lomiko Announces Corporate Update, Investor Relations Representation and Membership in The Accelerate Alliance

Retrieved on: 
Tuesday, January 4, 2022
Natural Resources, Alternative Energy, Energy, Environment, Mining, Minerals, Zero, Lithium, No, National instrument, Metal, Company, Mining, Mineral, Algonquin people, Human, ZEV, First Nations, National Financial Reporting Authority, Technology-critical element, CEO, Acceleration, SEDAR, Techno-economic assessment, MD, Kitigan Zibi Anishinabeg, Marketing, Eeyou Istchee James Bay Regional Government, TSX Venture Exchange, Nemaska Lithium, Legislation, News, Algonquin Nation Programs and Services Secretariat, Industry, Technical report, FLI, LMR, Outaouais, Risk management, Oil, COVID-19

Lomiko is starting 2022 as a member of The Accelerate Alliance, a national initiative aligning members on policies and programs to accelerate the development of the Zero-Emission Vehicle (ZEV) supply chain.

Key Points: 
  • Lomiko is starting 2022 as a member of The Accelerate Alliance, a national initiative aligning members on policies and programs to accelerate the development of the Zero-Emission Vehicle (ZEV) supply chain.
  • Matthew Fortier, President and CEO of Accelerate said: "We are very happy that Lomiko Metals has joined Accelerate.
  • Lomiko has retained the services of Refined Substance Inc., principally owned by Kimberly Darlington, to provide investor relations representation and communications advisory services to the company in English and French.
  • Under the terms of the agreement, Refined Substance will provide investor relations services, including press release preparation and distribution, management of investor inquiries, public and media relations outreach, and other communications services for Lomiko.